Cargando…
The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer’s disease, other types of dementia and non-demented controls: A cross-sectional study
Evidence indicate that the brain-specific protein, brevican, is proteolytically cleaved during neurodegeneration, hence positioning fragments of brevican as potential blood biomarkers of neurodegenerative diseases, such as dementia. We aimed to develop two assays capable of detecting the brevican N-...
Autores principales: | Jonesco, Ditte S., Karsdal, Morten A., Henriksen, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304580/ https://www.ncbi.nlm.nih.gov/pubmed/32559242 http://dx.doi.org/10.1371/journal.pone.0234632 |
Ejemplares similares
-
A caspase-6-cleaved fragment of Glial Fibrillary Acidic Protein as a potential serological biomarker of CNS injury after cardiac arrest
por: Jonesco, Ditte S., et al.
Publicado: (2019) -
The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease
por: Inekci, Dilek, et al.
Publicado: (2015) -
Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain
por: Ajmo, Joanne M, et al.
Publicado: (2008) -
ADAMTS4 and ADAMTS5 Knockout Mice Are Protected from Versican but Not Aggrecan or Brevican Proteolysis during Spinal Cord Injury
por: Demircan, Kadir, et al.
Publicado: (2014) -
Matrilin-2 Is Proteolytically Cleaved by ADAMTS-4 and ADAMTS-5
por: Wang, Zhengke, et al.
Publicado: (2014)